The cost effectiveness of BuccolamTM (midazolam oromucosal solution) for the treatment of prolonged acute epileptic seizures in Switzerland

Publication Type:
Poster


Citation:

Lee D, Beaudet A, Kidd R, Tate E and Akehurst R. The cost effectiveness of BuccolamTM (midazolam oromucosal solution) for the treatment of prolonged acute epileptic seizures in Switzerland. 2nd Swiss Federation of Clinical Neuro-Societies (SFCNS) Congress. Montreux, Switzerland. 5-7 June 2013. Poster P176.

 


Link to publication ⟶

⟵ Back to Search Results